ED

Eden Research PLCLSE Eden Research Stock Report

Last reporting period 31 Dec, 2023

Updated 08 Nov, 2024

Last price

Market cap $B

0.029

Micro

Exchange

XLON - London Stock Exchange

EDEN.L Stock Analysis

ED

Uncovered

Eden Research PLC is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-35/100

Low score

Market cap $B

0.029

Dividend yield

Shares outstanding

380.86 B

Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 16 full-time employees. The company went IPO on 2012-05-11. The firm provides crop protection products for foliar disease and insect control, open field and greenhouses, soil pests, post-harvest shelf-life extension, and seed treatment applications. Its crop protection product, Mevalone, is a biofungicide targeting Botrytis, which is available throughout the southern European Union zone, Kenya and Australia. Its Cedroz is a terpene-based product, formulated and patented by the Company as a post-planting solution to the problem of root-knot nematodes. The Company’s subsidiary includes TerpeneTech (UK), which is engaged in research and experimental development on biotechnology.

View Section: Eyestock Rating